All In MedTech

Device Trial Radar · NCT06133933

Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption

Total Shoulder Arthroplasty Preoperative Pain Threshold Prospective

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

131

Actual

Start

May 21, 2021

Primary completion

May 21, 2026

Study completion May 21, 2026

Sponsor

Lead sponsor
Cooper Norcross HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 18, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this prospective research study is to evaluate the effects of preoperative pain threshold using a pressure algometer and its effects on postoperative patient satisfaction, return to work, and opioid consumption following Total Shoulder Arthroplasty (TSA). Participants will have their pain threshold measured at the preoperative visit. Postoperatively, they will be followed for 3 months and complete a pain journal for 2 weeks, record their medications consumed, and complete surveys at 2 weeks, 6 weeks, and 3 months. The study team will rely on the completion of the questionnaires, opioid consumption journal, and surveys to establish a correlation between pre-operative pain threshold and post-operative outcome.

Conditions

  • Total Shoulder Arthroplasty
  • Postoperative Pain
  • Opioid Use

Interventions

  • Pain Threshold using algometer/dolorimeterDevice

    These patients who consent to participation in the study will receive a preoperative pain threshold measured using a pain algometer/dolorimeter. We will rely on the completion of the questionnaires, opioid consumption journal, and surveys to establish a correlation between pre-operative pain threshold and post-operative outcomes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Postoperative opioid consumptionTime frame: 3 months
  2. Postoperative satisfactionTime frame: 3 months
  3. Postoperative return to workTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cooper University Hospital

    Camden, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.